TELO
Telomir Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.32
-0.08 ▼ -5.71%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$1.29
-0.03 ▼ -2.26%
| Index | - | P/E | - | EPS (ttm) | -0.37 | Insider Own | 59.71% | Shs Outstand | 0.03B | Perf Week | 5.6% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | 17.86% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 6.65% | Short Float | 10.4% | Perf Quarter | -6.38% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | -0.77% | Short Ratio | 9.4 | Perf Half Y | -3.65% |
| Sales | 0.00B | P/B | 6.4 | EPS next 5Y | - | ROA | -266.47% | Short Interest | 1.44M | Perf YTD | -0.75% |
| Book/sh | 0.21 | P/C | 6.19 | EPS past 3/5Y | -391.99% - | ROE | -303.19% | 52W High | -75.56% ($5.40) | Perf Year | -73.76% |
| Cash/sh | 0.21 | P/FCF | - | Sales past 3/5Y | - | ROIC | -161.2% | 52W Low | 25.71% ($1.05) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 52.79% | Gross Margin | - | Volatility(W/M) | 9.16% 7.52% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.09 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 17.51 | EPS Q/Q | 83.19% | Profit Margin | - | RSI (14) | 53.48 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 17.51 | Sales Q/Q | - | SMA20 | 5.12% ($1.26) | Beta | -0.88 | Target Price | $8 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/09/03 | SMA50 | 3.59% ($1.27) | Rel Volume | 0.38 | Prev Close | $1.4 |
| Employees | 5 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -10.45% ($1.47) | Avg Volume(3M) | 0.15M | Price | $1.32 |
| IPO | 2024/2/9 | Option/Short | No/Yes | Trades | 391 | Volume | 58,321 | Change | -5.71% |
뉴스 로딩 중...